CHRO

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

Cocrystal Pharma to present data from Phase 1 study of first-in-class norovirus protease inhibitor CDI-988 at 9th International Calicivirus ConferenceJul 10, 2025
Channel Therapeutics announces positive efficacy results for NaV1.7 inhibitor in treating eye pain in multiple preclinical models.May 14, 2025